{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:00:57Z","timestamp":1787313657322,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 18KK0260"],"award-info":[{"award-number":["JP 18KK0260"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijoms.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ijom.2019.01.006","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T01:12:42Z","timestamp":1548551562000},"page":"908-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical features and mechanistic insights regarding IgG4-related dacryoadenitis and sialoadenitis: a review"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7877-2161","authenticated-orcid":false,"given":"T.","family":"Maehara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2019.01.006_bib0005","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijom.2019.01.006_bib0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Mahajan","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0015","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0020","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/259408","article-title":"Development of an IgG4-RD responder index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0030","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1365-2559.2011.03824.x","article-title":"Commentary on IgG4-related sialadenitis: Mikulicz\u2019s disease, Kuttner\u2019s tumour, and eponymy","volume":"58","author":"Harrison","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.ijom.2019.01.006_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14397595.2017.1290911","article-title":"Current approach to the diagnosis of IgG4-related disease - Combination of comprehensive diagnostic and organ-specific criteria","volume":"27","author":"Umehara","year":"2017","journal-title":"Modern rheumatology\/the Japan Rheumatism Association"},{"key":"10.1016\/j.ijom.2019.01.006_bib0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13075-015-0698-y","article-title":"Clinicopathological characteristics of immunoglobulin G4-related sialadenitis","volume":"17","author":"Li","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijom.2019.01.006_bib0050","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ijom.2014.06.014","article-title":"The diagnostic utility of biopsies from the submandibular and labial salivary glands in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease","volume":"43","author":"Moriyama","year":"2014","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.01.006_bib0055","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sj\u00f6gren\u2019s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sj\u00f6gren\u2019s Syndrome","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijom.2019.01.006_bib0060","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ijom.2019.01.006_bib0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2012.01.002","article-title":"Pathogenesis of Sj\u00f6gren\u2019s syndrome: what we know and what we should learn","volume":"39","author":"Tzioufas","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ijom.2019.01.006_bib0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/eji.1830240128","article-title":"Infiltrating T cells from patients with primary Sj\u00f6gren\u2019s syndrome express restricted or unrestricted T cell receptor V beta regions depending on the stage of the disease","volume":"24","author":"Legras","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaut.2012.05.019","article-title":"The T cell in Sj\u00f6gren\u2019s syndrome: force majeure, not spectateur","volume":"39","author":"Singh","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ijom.2019.01.006_bib0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/keh447","article-title":"Clinical and pathological differences between Mikulicz's disease and Sjogren\u2019s syndrome","volume":"44","author":"Yamamoto","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijom.2019.01.006_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2004.10.005","article-title":"Clinical and pathological characteristics of Mikulicz\u2019s disease (IgG4-related plasmacytic exocrinopathy)","volume":"4","author":"Yamamoto","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ijom.2019.01.006_bib0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bjoms.2016.10.021","article-title":"Differential diagnosis of IgG4-related sialadenitis, primary Sjogren syndrome, and chronic obstructive submandibular sialadenitis","volume":"55","author":"Hong","year":"2017","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.01.006_bib0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ultrasmedbio.2015.09.014","article-title":"Ultrasonographic Features of Immunoglobulin G4-Related Sialadenitis","volume":"42","author":"Li","year":"2016","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/jcp.2010.085613","article-title":"Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders","volume":"64","author":"Strehl","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0105","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ijom.2019.01.006_bib0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijom.2019.01.006_bib0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2177\/jsci.40.206","article-title":"IgG4-related disease\u2014mechanistic insights from both clinical and immunologic understanding of this condition","volume":"40","author":"Maehara","year":"2017","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.ijom.2019.01.006_bib0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08916934.2017.1280029","article-title":"Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease","volume":"50","author":"Mattoo","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ijom.2019.01.006_bib0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4 cytotoxic T lymphocytes in patients with IgG-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0130","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","article-title":"De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease","volume":"134","author":"Mattoo","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0135","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/gutjnl-2017-314861","article-title":"Deciphering the biology of Ig -related disease: specific antigens and disease?","volume":"67","author":"Haldar","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ijom.2019.01.006_bib0140","article-title":"Pathogenesis of IgG 4-related disease: a critical review","author":"Maehara","year":"2018","journal-title":"Odontology"},{"key":"10.1016\/j.ijom.2019.01.006_bib0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaut.2013.07.007","article-title":"T helper subsets in Sj\u00f6gren\u2019s syndrome and IgG4-related dacryoadenitis and sialoadenitis: a critical review","volume":"51","author":"Moriyama","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ijom.2019.01.006_bib0150","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.33320","article-title":"Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease","volume":"64","author":"Tanaka","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijom.2019.01.006_bib0155","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1136\/annrheumdis-2012-201477","article-title":"Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease","volume":"71","author":"Maehara","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijom.2019.01.006_bib0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/annrheumdis-2016-209139","article-title":"Lesional CD4+ IFN-gamma+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis","volume":"76","author":"Maehara","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijom.2019.01.006_bib0165","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fimmu.2016.00531","article-title":"Cytotoxic CD4 T cells: differentiation, function, and application to dengue virus infection","volume":"7","author":"Tian","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0170","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijom.2019.01.006_bib0175","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/art.40469","article-title":"A CD8alpha- subset of CD4\u2009+\u2009SLAMF7+ cytotoxic T cells is expanded in patients with IgG4-related disease and decreases following glucocorticoid treatment","volume":"70","author":"Della-Torre","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0180","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.coi.2011.10.007","article-title":"B cells and autoimmunity","volume":"23","author":"Pillai","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0185","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0190","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39209","article-title":"Brief Report: Number of Circulating Follicular Helper 2 T Cells Correlates With IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease","volume":"67","author":"Akiyama","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.ijom.2019.01.006_bib0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13075-016-1064-4","article-title":"Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease","volume":"18","author":"Akiyama","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijom.2019.01.006_bib0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fimmu.2017.00235","article-title":"T Cell Polarization toward TH2\/TFH2 and TH17\/TFH17 in Patients with IgG4-Related Disease","volume":"8","author":"Grados","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0205","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800050","article-title":"The expansion in lymphoid organs of IL-4(+) BATF(+) T follicular helper cells is linked to IgG4 class switching in vivo","volume":"1","author":"Maehara","year":"2018","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.ijom.2019.01.006_bib0210","article-title":"Identification of galectin-3 as an autoantigen in patients with IgG 4-related disease","author":"Perugino","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0215","first-page":"9312142","article-title":"High Expression of Galectin-3 in Patients with IgG4-Related Disease: A Proteomic Approach","volume":"2017","author":"Salah","year":"2017","journal-title":"Patholog Res Int"},{"key":"10.1016\/j.ijom.2019.01.006_bib0220","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/jpet.114.218370","article-title":"Functions of galectin-3 and its role in fibrotic diseases","volume":"351","author":"Li","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijom.2019.01.006_bib0225","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/gutjnl-2015-310336","article-title":"Pathogenicity of IgG in patients with IgG4-related disease","volume":"65","author":"Shiokawa","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.ijom.2019.01.006_bib0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaq0997","article-title":"Laminin 511 is a target antigen in autoimmune pancreatitis","volume":"10","author":"Shiokawa","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijom.2019.01.006_bib0235","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2008.172908","article-title":"Standard steroid treatment for autoimmune pancreatitis","volume":"58","author":"Kamisawa","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.ijom.2019.01.006_bib0240","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14397595.2016.1259602","article-title":"A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease","volume":"27","author":"Masaki","year":"2017","journal-title":"Modern Rheumatology\/the Japan Rheumatism Association"},{"key":"10.1016\/j.ijom.2019.01.006_bib0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13075-017-1507-6","article-title":"Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents","volume":"20","author":"Hong","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijom.2019.01.006_bib0250","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2016-312049","article-title":"Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis","volume":"66","author":"Masamune","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ijom.2019.01.006_bib0255","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.ijom.2019.01.006_bib0260","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00784-012-0905-z","article-title":"Clinical characteristics of Mikulicz\u2019s disease as an IgG4-related disease","volume":"17","author":"Moriyama","year":"2013","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.ijom.2019.01.006_bib0265","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/all.12342","article-title":"Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy","volume":"69","author":"Mattoo","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.ijom.2019.01.006_bib0270","doi-asserted-by":"crossref","first-page":"42413","DOI":"10.1038\/srep42413","article-title":"Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease","volume":"7","author":"Furukawa","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijom.2019.01.006_bib0275","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/rheumatology\/kex171","article-title":"Follicular helper T cells in the pathogenesis of IgG4-related disease","volume":"1","author":"Akiyama","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.ijom.2019.01.006_bib0280","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MPA.0b013e3181577553","article-title":"Circulating naive and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis","volume":"36","author":"Miyoshi","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.ijom.2019.01.006_bib0285","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/MPA.0b013e31821fc796","article-title":"Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis","volume":"40","author":"Kusuda","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.ijom.2019.01.006_bib0290","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00535-010-0199-3","article-title":"Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases","volume":"45","author":"Koyabu","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ijom.2019.01.006_bib0295","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.21697","article-title":"Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis","volume":"45","author":"Zen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ijom.2019.01.006_bib0300","first-page":"728","article-title":"Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease","volume":"67","author":"Hubers","year":"2018","journal-title":"Gut"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502719300098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502719300098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:30:17Z","timestamp":1760272217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0901502719300098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0901502719300098"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2019.01.006","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and mechanistic insights regarding IgG4-related dacryoadenitis and sialoadenitis: a review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijom.2019.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}